Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.

Blood·2026
Same author

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

Nature communications·2026
Same author

A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment.

Blood·2025
Same author

In vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis.

bioRxiv : the preprint server for biology·2025
Same author

A developmental route to hematopoietic stem cells.

Nature biotechnology·2024
Same author

Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors.

Nature biotechnology·2024

Related Experiment Video

Updated: Aug 5, 2025

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

10.0K

In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation.

Yavor K Bozhilov1, Ian Hsu1, Elizabeth J Brown1

  • 1MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.

Cells
|March 29, 2023
PubMed
Summary
This summary is machine-generated.

Hematopoiesis, the process of blood cell formation, relies on hematopoietic stem cells (HSCs). This review explores in vitro culture methods for HSC expansion and differentiation, crucial for research and clinical applications.

Keywords:
B cellT celldifferentiationerythrocyteexpansionhaematopoiesishaematopoietic stem cellsin vitromegakaryocytemonocyteneutrophilself-renewal

More Related Videos

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
09:00

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on: June 16, 2019

9.6K
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

11.1K

Related Experiment Videos

Last Updated: Aug 5, 2025

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

10.0K
Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition
09:00

Hemogenic Endothelium Differentiation from Human Pluripotent Stem Cells in A Feeder- and Xeno-free Defined Condition

Published on: June 16, 2019

9.6K
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

11.1K

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Cellular Biology

Background:

  • The hematopoietic system generates diverse blood and immune cells, including erythrocytes, megakaryocytes, and lymphocytes.
  • Self-renewing hematopoietic stem cells (HSCs) and progenitor cells continuously replenish mature blood cell populations, maintaining homeostasis.
  • This vital process, known as hematopoiesis, is primarily regulated within the bone marrow.

Purpose of the Study:

  • To review in vitro culture protocols for human HSC expansion and differentiation.
  • To summarize key factors influencing HSC behavior in culture.
  • To highlight the utility of in vitro systems for studying human hematopoiesis and developing cell-based therapies.

Main Methods:

  • Review of established in vitro culture systems for hematopoietic stem and progenitor cells.
  • Analysis of methods utilizing recombinant cytokines, co-culture systems, and small molecules.
  • Discussion of protocols for both HSC expansion and lineage-specific differentiation.

Main Results:

  • In vitro culture systems provide tractable models for studying human hematopoiesis.
  • Various protocols exist for expanding HSCs and directing their differentiation into specific lineages.
  • These systems are instrumental in advancing cell therapy and transfusion medicine.

Conclusions:

  • In vitro culture techniques are essential for understanding human hematopoiesis and its regulation.
  • Optimized protocols are critical for successful HSC expansion and differentiation.
  • These advancements hold significant promise for transplantation and transfusion medicine applications.